Cross Country Healthcare Files 8-K

Ticker: CCRN · Form: 8-K · Filed: 2024-05-23T00:00:00.000Z

Sentiment: neutral

Topics: filing, disclosure

Related Tickers: CCRH

TL;DR

CCRH filed an 8-K, likely containing updates. Watch for details.

AI Summary

On May 23, 2024, Cross Country Healthcare, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt.

Why It Matters

This filing indicates that Cross Country Healthcare, Inc. is providing updates or disclosures to the SEC, which could contain important information for investors.

Risk Assessment

Risk Level: low — The provided excerpt is a standard 8-K filing notification and does not contain specific material information that would indicate a high risk.

Key Players & Entities

FAQ

What specific information is being disclosed in this 8-K filing?

The filing indicates it is for Regulation FD Disclosure and Financial Statements and Exhibits, but the specific details are not provided in the excerpt.

When was this 8-K report filed?

The report was filed on May 23, 2024.

What is the principal executive office address for Cross Country Healthcare, Inc.?

The principal executive office is located at 6551 Park of Commerce Boulevard, N.W., Boca Raton, FL 33487.

What is the Commission File Number for Cross Country Healthcare, Inc.?

The Commission File Number is 0-33169.

What is the company's telephone number as listed in the filing?

The company's telephone number is (561) 998-2232.

From the Filing

0001628280-24-024957.txt : 20240523 0001628280-24-024957.hdr.sgml : 20240523 20240523162311 ACCESSION NUMBER: 0001628280-24-024957 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240523 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240523 DATE AS OF CHANGE: 20240523 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CROSS COUNTRY HEALTHCARE INC CENTRAL INDEX KEY: 0001141103 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HELP SUPPLY SERVICES [7363] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 134066229 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-33169 FILM NUMBER: 24978618 BUSINESS ADDRESS: STREET 1: 6551 PARK OF COMMERCE BOULEVARD, N.W. CITY: BOCA RATON STATE: FL ZIP: 33487 BUSINESS PHONE: 8003472264 MAIL ADDRESS: STREET 1: 6551 PARK OF COMMERCE BOULEVARD, N.W. CITY: BOCA RATON STATE: FL ZIP: 33487 FORMER COMPANY: FORMER CONFORMED NAME: CROSS COUNTRY INC DATE OF NAME CHANGE: 20010521 8-K 1 ccrn-20240523.htm 8-K ccrn-20240523 0001141103 FALSE 0001141103 2024-05-23 2024-05-23 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.  20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 23, 2024 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 6551 Park of Commerce Boulevard, N.W. , Boca Raton , FL 33487 (Address of Principal Executive Office) (Zip Code) ( 561 ) 998-2232 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Securities registered pursuant to Section 12(b) of the Act:     Title of each class                 Trading Symbol         Name of each exchange on which registered Common stock, par value $0.0001 per share          CCRN              The Nasdaq Stock Market LLC Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 7.01    Regulation FD Disclosure. On May 23, 2024, the Company issued a press release, a copy of which is furnished herewith as Exhibit 99.1. Pursuant to General Instruction B.2 of Current Report on Form 8-K, the information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Excha

View on Read The Filing